123 related articles for article (PubMed ID: 37931916)
1. The Presence of Anti-TPO Antibodies Increase the Likelihood of Post-I131 Hypothyroidism.
Quataert F; Bravenboer B; Keyaerts M; Andreescu CE
Horm Metab Res; 2024 Feb; 56(2):134-141. PubMed ID: 37931916
[TBL] [Abstract][Full Text] [Related]
2. Long-term follow-up study of radioiodine treatment of hyperthyroidism.
Metso S; Jaatinen P; Huhtala H; Luukkaala T; Oksala H; Salmi J
Clin Endocrinol (Oxf); 2004 Nov; 61(5):641-8. PubMed ID: 15521969
[TBL] [Abstract][Full Text] [Related]
3. Predictors of Hypothyroidism Following Empirical Dose Radioiodine in Toxic Thyroid Nodules: Real-Life Experience.
Demir BK; Karakilic E; Saygili ES; Araci N; Ozdemir S
Endocr Pract; 2022 Aug; 28(8):749-753. PubMed ID: 35537668
[TBL] [Abstract][Full Text] [Related]
4. [Short-term results of treatment with 131I in patients with multinodular goiter: effect of the associated degree of hyperthyroidism and other variables].
Boj Carceller D; Liévano Segundo P; Navarro Beltrán P; Sanz París A; de Castro Hernández P; Monreal Villanueva M; Abós Olivares D
Rev Esp Med Nucl; 2011; 30(3):156-61. PubMed ID: 21481495
[TBL] [Abstract][Full Text] [Related]
5. Predictive factors for early hypothyroidism following the radioactive iodine therapy in Graves' disease patients.
Hu RT; Liu DS; Li B
BMC Endocr Disord; 2020 May; 20(1):76. PubMed ID: 32471411
[TBL] [Abstract][Full Text] [Related]
6. Factors affecting timing of hypothyroidism following radioactive iodine therapy (RAIT) for patients with Graves' disease: A 12-month observational study.
Mahmoud HA; Alsanory AAAA; Mostafa HG; Hassan ER
Nucl Med Commun; 2024 Jun; 45(6):499-509. PubMed ID: 38586956
[TBL] [Abstract][Full Text] [Related]
7. Cohort study on radioactive iodine-induced hypothyroidism: implications for Graves' ophthalmopathy and optimal timing for thyroid hormone assessment.
Stan MN; Durski JM; Brito JP; Bhagra S; Thapa P; Bahn RS
Thyroid; 2013 May; 23(5):620-5. PubMed ID: 23205939
[TBL] [Abstract][Full Text] [Related]
8. Radioactive iodine therapy for pediatric Graves' disease: a single-center experience over a 10-year period.
Kaplowitz PB; Jiang J; Vaidyanathan P
J Pediatr Endocrinol Metab; 2020 Mar; 33(3):383-389. PubMed ID: 31603857
[TBL] [Abstract][Full Text] [Related]
9. Human recombinant TSH preceding a therapeutic dose of radioiodine for multinodular goiters has no significant effect in the surge of TSH-receptor and TPO antibodies.
Rubio IG; Perone BH; Silva MN; Knobel M; Medeiros-Neto G
Thyroid; 2005 Feb; 15(2):134-9. PubMed ID: 15753672
[TBL] [Abstract][Full Text] [Related]
10. Radioiodine therapy in patients with amiodarone-induced thyrotoxicosis (AIT).
Czarnywojtek A; Czepczynski R; Ruchala M; Wasko R; Zgorzalewicz-Stachowiak M; Szczepanek E; Zamyslowska H; Bartkowiak Z; Florek E; Sowinski J
Neuro Endocrinol Lett; 2009; 30(2):209-14. PubMed ID: 19675515
[TBL] [Abstract][Full Text] [Related]
11. Treatment of post-radioactive iodine relapse of hyperthyroidism: comparison of long-term methimazole and radioactive iodine treatment.
Saadat N; Azizi F; Abdi H; Amouzegar A
J Endocrinol Invest; 2022 Oct; 45(10):1919-1924. PubMed ID: 35610532
[TBL] [Abstract][Full Text] [Related]
12. Effect of liver dysfunction on outcome of radioactive iodine therapy for Graves' disease.
Ze Y; Shao F; Feng X; Shen S; Bi Y; Zhu D; Zhang X
BMC Endocr Disord; 2022 Dec; 22(1):319. PubMed ID: 36522617
[TBL] [Abstract][Full Text] [Related]
13. Radioiodine treatment of hyperthyroidism. Success rate and influence of thyrostatic medication.
Ghadban WK; Zirie MA; Al-Khateeb DA; Jayyousi AA; Mobayedh HM; El-Aloosy AS
Saudi Med J; 2003 Apr; 24(4):347-51. PubMed ID: 12754531
[TBL] [Abstract][Full Text] [Related]
14. Development of hypothyroidism over 13 years of follow-up of patients with hyperthyroidism after radioiodine therapy.
Li JF; Xie LJ; Qin LP; Wan QC; Li JP; Wu QY; Cheng MH
Hell J Nucl Med; 2022; 25(1):26-31. PubMed ID: 35388801
[TBL] [Abstract][Full Text] [Related]
15. A Prospective Study to Evaluate the Possible Role of Cholecalciferol Supplementation on Autoimmunity in Hashimoto's Thyroiditis.
Bhakat B; Pal J; Das S; Charaborty SK; SircarMedical NR; Kolkata ; RGKar ; NorthBengal ; Siliguri
J Assoc Physicians India; 2023 Jan; 71(1):1. PubMed ID: 37116030
[TBL] [Abstract][Full Text] [Related]
16. Incidence of Hypothyreoidism after Radioactive Iodine-I131 Treatment in Dependance of Hyperthyreoidism Etiology and Therapy Dose.
Beslic N; Licina S; Sadija A; Milardovic R
Med Arch; 2017 Aug; 71(4):270-273. PubMed ID: 28974848
[TBL] [Abstract][Full Text] [Related]
17. Objective estimates of the probability of developing hypothyroidism following radioactive iodine treatment of thyrotoxicosis.
Ahmad AM; Ahmad M; Young ET
Eur J Endocrinol; 2002 Jun; 146(6):767-75. PubMed ID: 12039696
[TBL] [Abstract][Full Text] [Related]
18. TPO antibody status prior to first radioactive iodine therapy as a predictive parameter for hypothyroidism in Graves' disease.
Verdickt S; Van Nes F; Moyson C; Maes T; Van Crombrugge P; Van den Bruel A; Decallonne B
Eur Thyroid J; 2022 Aug; 11(4):. PubMed ID: 35687484
[TBL] [Abstract][Full Text] [Related]
19. Long-term Effects of Radioiodine in Toxic Multinodular Goiter: Thyroid Volume, Function, and Autoimmunity.
Roque C; Santos FS; Pilli T; Dalmazio G; Castagna MG; Pacini F
J Clin Endocrinol Metab; 2020 Jul; 105(7):. PubMed ID: 32320467
[TBL] [Abstract][Full Text] [Related]
20. Radioiodine treatment of hyperthyroidism: prognostic factors affecting outcome.
Erem C; Kandemir N; Hacihasanoglu A; Ersöz HO; Ukinc K; Kocak M
Endocrine; 2004 Oct; 25(1):55-60. PubMed ID: 15545707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
